Floxuridine

Floxuridine is a type of chemotherapy medicine. It's used to treat certain types of cancer, like those that have spread to the liver. It works by stopping cancer cells from growing. It's given in a special way, usually through a vein in the liver, to help it work best.

Brand names:FUdR, Fluorodeoxyuridine
Medication

What people taking Floxuridine report

Every report comes from a Lived member, sent anonymously.

Have you tried Floxuridine for Colorectal Cancer?

NameHow it went

About Floxuridine

What It's For

Floxuridine (originally sold under the brand name FUDR, still a common shorthand) is a chemotherapy medicine used for cancer in the liver. Instead of going into a vein, it is infused directly into the hepatic artery, the main artery supplying the liver, so that most of the drug reaches the liver tumors and relatively little reaches the rest of the body. Its FDA-approved use is to control cancer of the digestive tract, most often colorectal cancer, that has spread to the liver, in carefully selected people whose liver tumors cannot be cured by surgery or other means. The approval is for palliative treatment: the aim is to control the cancer in the liver rather than to cure it. It suits people whose cancer is largely confined to the liver. When the cancer has spread more widely, chemotherapy that circulates through the whole body is usually the better choice. Specialized cancer centers also use floxuridine in ways the original label does not cover: combined with standard chemotherapy to try to shrink liver tumors enough for surgery, after surgery to remove liver metastases, and for intrahepatic cholangiocarcinoma, a cancer of the bile ducts inside the liver. These uses rest on smaller studies, with mixed results after surgery, and on trials still under way, and they are offered mainly where an experienced team runs a liver infusion program.

How It Works

Floxuridine is an antimetabolite, a drug that resembles one of the building blocks cells use to copy their DNA. Once inside a cell it interferes with DNA production, so rapidly dividing cells such as cancer cells are damaged or stop growing. It is closely related to fluorouracil (5-FU), a widely used chemotherapy, and when it is injected quickly the body converts it into fluorouracil. The infusion route is what makes floxuridine distinctive. Healthy liver tissue gets most of its blood from the portal vein, which drains the intestines, while tumors that have spread to the liver are fed mainly by the hepatic artery. Infusing the drug into that artery therefore delivers much higher concentrations to the tumors than the same drug given into a vein. The liver also breaks down much of the floxuridine as it passes through, which limits how much reaches the rest of the body. The trade-off is that the liver and its bile ducts bear the brunt of the drug's effects.

Dosage & Administration

Floxuridine is given only by a specialized cancer team. Today it is most often delivered through a hepatic arterial infusion (HAI) pump: during an operation, a surgeon places a small pump under the skin of the abdomen and connects its catheter to an artery leading to the liver. Imaging beforehand checks that this artery supplies the liver alone and that liver function is adequate. The pump releases the drug steadily on its own. In common protocols, floxuridine runs for 14 days of each 28-day cycle, and the pump is refilled every 2 weeks through the skin with a special needle, alternating between chemotherapy and a saline (salt water) solution. Many centers add dexamethasone, a steroid, to the pump; in an early trial it was linked with better tumor response and a trend toward smaller rises in bilirubin (a blood marker that rises when bile flow from the liver is impaired). Heparin, a blood thinner, is often added to help keep the catheter open. HAI is usually combined with chemotherapy given into a vein. The dose is calculated from body weight and adjusted frequently, mainly on the basis of liver blood tests. The original label describes higher doses than many centers now use, and several programs have lowered their starting doses to reduce liver and bile duct injury.

Side Effects

Common effects include nausea, vomiting, diarrhea, loss of appetite, abdominal cramps, tiredness and mouth sores. Hair thinning or loss can happen and is usually temporary. Because the drug is concentrated in the liver, abnormal liver blood tests are common. The most important problem specific to liver infusion is injury to the bile ducts, the tubes that carry bile out of the liver. Inflammation can scar and narrow them (biliary sclerosis), which happens in about 5 in 100 people treated with HAI and can require a stent to keep bile flowing. It usually shows up first as rising bilirubin or other liver test results, which is why the team checks these before each refill and pauses or lowers the dose when they climb. Yellowing of the skin or eyes should be reported. Ulcers and inflammation of the stomach or duodenum (the first part of the small intestine) can also occur, often felt as burning upper abdominal pain. Floxuridine can lower blood counts, which raises the risk of infection and bleeding, and the pump and catheter can develop problems such as infection or bleeding at the pump site or a blocked or displaced catheter. The label says treatment should stop promptly at the first signs of serious toxicity, so contact the care team right away about mouth or throat sores, vomiting that will not stop, frequent or watery diarrhea, fever or other signs of infection, or unusual bleeding or bruising. Also call about new pain, redness or swelling over the pump. Chest pain, vomiting blood or material that looks like coffee grounds, or black or bloody stools need emergency care.

Interactions & Warnings

Floxuridine is a highly toxic drug with a narrow margin between an effective dose and a harmful one. Severe drops in blood counts and bleeding from the stomach or intestines can occur even with careful dosing, so the label calls for the first course to be given in the hospital and for close supervision throughout. It is not given to people who are poorly nourished, whose bone marrow is already not making enough blood cells, or who have a potentially serious infection. Extra caution is needed with reduced liver or kidney function, past high-dose radiation to the pelvis, or earlier treatment with alkylating agents, a class of chemotherapy drugs. Anything else that suppresses the bone marrow, makes eating harder or strains the body, such as surgery or a serious infection, raises floxuridine's toxicity. That includes the chemotherapy usually given alongside it, which is why the two are dosed and monitored together. Anyone allergic to fluorouracil should tell the team, and the prescriber and pharmacist should see a full list of medicines, vitamins and supplements. Floxuridine can harm a developing baby. Pregnancy should be avoided during treatment, and anyone who becomes pregnant should tell the care team promptly. Breastfeeding is not advised while receiving it.

What to Expect

Starting HAI treatment involves surgery to place the pump, followed by a recovery period before the first infusion. After that, life follows the refill schedule: a clinic visit every 2 weeks for blood tests and a refill, usually coordinated with any chemotherapy given into a vein. Between visits the pump works on its own, with nothing to switch on or adjust. Heat and lower outside pressure make it deliver the drug faster, so avoid hot tubs, saunas and heating pads over the pump, avoid scuba diving, and check with the team before flying or traveling to high altitude; the team's own instructions take precedence. Dose pauses and reductions are common, especially when liver tests rise, and treatment can usually resume once side effects settle. A pause is a routine safety step rather than a sign that treatment has failed. Response is checked with periodic imaging. How long treatment continues depends on its purpose: a planned number of cycles after surgery, or as long as the cancer responds and side effects stay manageable when the goal is control or shrinking tumors for an operation. Because HAI treats only the liver, cancer can still appear elsewhere in the body, which is why chemotherapy through the bloodstream is usually continued alongside it. Results vary widely. For some people with tumors confined to the liver, the combination shrinks tumors enough for surgery; for others it mainly slows the disease.

Questions to Ask Your Doctor

  1. 1.Is my cancer confined enough to the liver for pump treatment to make sense, and what are the alternatives?
  2. 2.What is the goal of floxuridine in my case: shrinking tumors for surgery, lowering the chance of the cancer returning after surgery, or controlling the disease?
  3. 3.How much experience does this center have with liver infusion pumps, and who manages the pump between visits?
  4. 4.Which liver test changes would lead you to pause or lower the dose, and how will you watch for bile duct injury?
  5. 5.Which symptoms should I call about right away, and how do I reach the team after hours?

Last reviewed • Oct 2026

Educational content, not medical advice.